Cellcom Israel (CEL) Posts Mixed Q2 Results

Cellcom Israel (NYSE: CEL) reported Q2 EPS of NIS1.22, NIS0.22 better than the analyst estimate of NIS1.00. Revenue for the quarter came in at NIS1.5 billion versus the consensus estimate of NIS1.56 billion.

For earnings history and earnings-related data on Cellcom Israel (CEL) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Intuitive Machines, Inc. (LUNR) Misses Q2 EPS by 20c, Misses on Revenue; Offers FY26 Revenue Guidance
• Aeroflex Holdings (ARX) Tops Q2 EPS by 15c